Tower Research Capital (TRC)’s Korro Bio KRRO Stock Holding History
Bought
Maintained
Sold
Other funds holding KRRO
LCM
Tower Research Capital (TRC)'s KRRO Position: Q3 2026 in Review
Tower Research Capital (TRC) increased its Korro Bio (KRRO) stake by 211% in Q3 2026, buying an estimated $41.2K and bringing the position to 4,935 shares worth $48.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3239.
Tower Research Capital (TRC) first reported a position in KRRO in Q4 2019 and has held it in 25 quarters since. The position peaked at $446K in Q3 2020. 104 funds tracked by Wall St. Rank hold KRRO as of Q3 2026.
- Tower Research Capital (TRC) held 4,935 shares of Korro Bio worth $48.9K as of Q3 2026.
- Tower Research Capital (TRC) bought 3,348 Korro Bio shares in Q3 2026, an estimated $41.2K.
- Korro Bio made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q3 2026, its #3239 holding.
- Tower Research Capital (TRC) first reported a position in Korro Bio in Q4 2019 and has held it in 25 quarters since.
- Tower Research Capital (TRC)'s Korro Bio position peaked at $446K in Q3 2020.
- 104 funds tracked by Wall St. Rank held Korro Bio as of Q3 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2026, filed 16 Nov 2026.